炎癥介質(zhì)與抗炎藥物_第1頁
炎癥介質(zhì)與抗炎藥物_第2頁
炎癥介質(zhì)與抗炎藥物_第3頁
炎癥介質(zhì)與抗炎藥物_第4頁
炎癥介質(zhì)與抗炎藥物_第5頁
已閱讀5頁,還剩19頁未讀 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

炎癥介質(zhì)與抗炎藥物Inflammation(炎癥)Theclassicalsignsofinflammationareredness,swelling,heat,pain,andlossoffunction.

SkinabscessPneumoniaTheProcessofInflammation1.Initiationoftheeventbyaforeignsubstanceorphysicalinjury2.Recruitmentandchemoattractionofinflammatorycells,andactivationofthesecells3.Releaseinflammatorymediatorscapableofdamagingorkillinganinvadingmicrobeortumor.Insomeinstances,theinflammatoryresponseisinitiatedbyanotherwiseharmlessforeignmaterial(e.g.,pollen).Inflammationcanalsoresultfromanautoimmuneresponsetothehost’sowntissue,asoccursinrheumatoidarthritis.Whydoweneedanti-inflammatorydrugs?Inmostcases,theinflammatoryresponseeventuallysubsides,butifsuchaself-limitingregulationdoesnotoccur,theinflammatoryresponsewillrequirepharmacologicalintervention.Theneedforanti-inflammatorydrugsariseswhentheinflammatoryresponseisinappropriate,aberrant,sustained,orcausesdestructionoftissue.Hosttissuemayundergoinjury,sincemanyoftheinflammatorymediatorsarenotspecificforaparticulartissuetarget.THEINFLAMMATORYPROCESSThephasesofinflammatoryresponsesRapidphase:secondstominutes,consistingofvasodilation,increasedbloodflow,edema,andpain.Chronicphase:overmonthstoyears;dramaticallyincreasedproductionofinflammatorymediators.AsthmaSecondarychronicphaseofinflammation:afteryearsofoxidativedamagehasdegradedbloodvesselsandtissues.Suchchronicinflammationappearstoplayaroleinmanydiseasestates,suchasarteriosclerosisandcancer.動(dòng)脈硬化InflammatoryMediatorsEicosanoids類花生酸Theeicosanoids,derivedfroma20-carbonunsaturatedfattyacid,arachidonicacid(eicosatetraenoicacid),areobtainedfrommembranephospholipidsandsynthesizeddenovoatthetimeofcellularstimulation.ArachidonateMetabolismPathways

Phospholipids

ArachidonicAcid

COX-2COX-1Oldanti-inflammatorydrugtarget

ProstaglandinH2

PGI2

PGF2α

PGE2PGD2TXA2

PhospholipaseA2PGESPGES:prostaglandinEsynthase,anewanti-inflammatorydrugtargetPGDH15-keto-PGE2Cyclooxygenase(COX)Twoisoforms:COX-1:Constitutiveor“housekeeping”isoformthatisresponsibleforthebasalproductionofprostaglandins,prostacyclins,andthromboxanes.COX-2:Induciblebycytokinesandotherinflammatorystimuliandisbelievedtopredominateduringchronicinflammation.ThefinalproductoftheCOXpathwayistissuespecific.Forexample,plateletsproducethromboxaneA2(TxA2);vascularendothelialcellsproduceprostacyclin(PGI2);mastcellsproduceprostaglandinD2(PGD2);COX-2selectiveinhibitorssuperiortonon-selectiveinhibitors?15-ProstaglandinDehydrogenaseCOX-2and15-PGDHapricoxibNONSTEROIDALANTIINFLAMMATORY

DRUGS(NSAIDs)Thenonsteroidalanti-inflammatorydrugs(NSAIDs)haveavarietyofclinicalusesasantipyretics,analgesics,andanti-inflammatoryagents.Unliketheopioidanalgesics,theydonotcauseneurologicaldepressionordependence.NSAIDsreducepainandinflammationassociatedwithrheumatoiddiseasesbutdonotdelayorreversethedisease’sprogress.MechanismofAction

Theanti-inflammatoryactionsoftheNSAIDsaremostlikelyexplainedbytheirinhibitionofprostaglandinsynthesisbyCOX-2.TheCOX-2isoformisthepredominantCOXinvolvedintheproductionofprostaglandinsduringinflammatoryprocesses.ProstaglandinsoftheEandFseriesevokesomeofthelocalandsystemicmanifestationsofinflammation,suchasvasodilation,hyperemia,increasedvascularpermeability,swelling,pain,andincreasedleukocytemigration.AdverseEffectsofNSAIDs

AnumberofthetoxicitiescommonlycausedbytheNSAIDsresultfromtheinhibitionofprostaglandinsynthesis.TheabilityofNSAIDstoincreasegastricacidsecretionandinhibitbloodclottingcanleadtoGItoxicity.BiologicalOxidantsThebiologicallyderivedoxidantsarepotentbacterialkillersbutarealsoamajorcontributingfactorintissueinjurythatresultsfromtheinflammatoryresponse.Theseoxidantsincludethesuperoxideanion(?O2-),hydrogenperoxide(H2O2),nitricoxide(NO),peroxynitrite(OONO),hypochlorousacid(HOClTheseoxidants,largelygeneratedbyphagocyticcellssuchasneutrophilsandmacrophages,inducetissueinjurybeyondthatproducedbydigestiveenzymesandeicosanoids.Inhibitionofproductionoftheseoxidantsorinactivationofthesesubstancesbyantioxidantsisanimportantstrategyforthetreatmentofinflammatorydisorders.CytokinesTNF-andIL-1areproducedprimarilybycellsofthemonocyte–macrophagelineage.Theyworkinconcerttostimulateinflammatoryresponsessuchaspain,fever,andtherecruitmentoflymphocytes.Inaddition,theyinduceproductionofmanyotherinflammatorymediatorsandcontributetothetissuedamageseeninchronicinflammation.ApproximatelyonemillionindividualsworldwideareeitherundergoingtreatmentorhavebeentreatedwithTNFinhibitorsavailableinthepharmaceuticalmarket,encompassingindicationsthatincluderheumatoidarthritis,psoriaticarthritis牛皮癬性關(guān)節(jié)炎,psoriasis銀屑病andinflammatoryboweldiseases炎癥性腸病糖皮質(zhì)激素(Glucocorticoid),又名“腎上腺皮質(zhì)激素”,是由腎上腺皮質(zhì)分泌的一類甾體激素

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論